COM:CATALYSTPHARMA
Catalyst Pharmaceuticals, Inc.
- Stock
Last Close
21.12
22/11 21:00
Market Cap
2.56B
Beta: -
Volume Today
863.01K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 28.01K - | 1.01M 3,493.52% | 3.30M 228.27% | 6.26M 89.49% | 7.34M 17.21% | 11.22M 52.97% | ||||||
average payables | 1.11M - | 1.33M 20.24% | 1.80M 35.40% | 1.36M 24.42% | 1.44M 5.55% | 2.14M 48.78% | 3.23M 50.71% | 4.19M 29.72% | 3.51M 16.12% | 3.37M 4.00% | 9.38M 178.36% | |
average receivables | 5.27M - | 8.26M 56.82% | 6.30M 23.71% | 8.53M 35.31% | 31.98M 274.91% | |||||||
book value per share | 0.47 - | 0.55 16.75% | 0.69 24.87% | 0.47 30.87% | 0.94 98.94% | 0.49 47.56% | 0.85 72.03% | 1.64 92.48% | 2.00 22.11% | 2.91 45.26% | 0.00 99.88% | |
capex per share | -0.00 - | -0.00 330.66% | -0.00 67.53% | -0.00 299.42% | -0.00 - | -0.00 79.01% | -0.00 41.48% | -0.01 8,869.29% | -0.00 97.16% | -0.00 99.28% | ||
capex to depreciation | -0.42 - | -2.16 414.19% | -0.68 68.44% | -2.21 225.08% | -2.42 - | -0.07 97.31% | -0.01 80.21% | -5.32 41,204.24% | -0.02 99.56% | -0.01 69.98% | ||
capex to operating cash flow | 0.00 - | 0.00 363.76% | 0.00 70.59% | 0.01 310.56% | 0.00 - | -0.00 115.63% | -0.00 54.77% | -0.02 6,582.06% | -0.00 98.52% | -0.00 543.71% | ||
capex to revenue | -0.18 - | -0.00 99.90% | -0.00 49.44% | -0.01 7,473.65% | -0.00 98.13% | -0.00 328.48% | ||||||
cash per share | 0.52 - | 0.61 17.38% | 0.72 17.95% | 0.49 32.49% | 0.98 100.83% | 0.52 46.78% | 0.92 76.20% | 1.36 47.60% | 1.85 36.52% | 2.89 56.02% | 0.00 99.96% | |
days of inventory on hand | 48.39 - | 99.62 105.86% | 131.26 31.76% | 72.22 44.98% | 109.88 52.15% | |||||||
days payables outstanding | 101.83 - | 91.17 10.47% | 46.17 49.36% | 42.19 8.62% | 103.92 146.33% | |||||||
days sales outstanding | 37.59 - | 18.35 51.18% | 17.15 6.53% | 17.79 3.69% | 49.05 175.76% | |||||||
debt to assets | 0.01 - | 0.00 98.23% | 0.02 11,714.00% | 0.01 41.34% | 0.01 34.58% | |||||||
debt to equity | 0.01 - | 0.00 98.43% | 0.02 11,875.40% | 0.01 36.20% | 0.01 36.59% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.14 - | -0.08 40.63% | -0.10 25.45% | -0.21 103.35% | -0.05 73.57% | -0.17 214.41% | 0.08 147.85% | 0.22 162.66% | 0.06 73.99% | 0.04 23.41% | 0.00 99.91% | |
enterprise value | 86.42M - | 181.41M 109.92% | 169.87M 6.36% | 73.13M 56.95% | 277.99M 280.15% | 180.50M 35.07% | 297.18M 64.64% | 215.50M 27.49% | 532.33M 147.02% | 1.63B 205.88% | 1.91T 117,328.93% | |
enterprise value over ebitda | -10.29 - | -13.37 29.92% | -8.30 37.90% | -3.63 56.32% | -15.03 314.56% | -5.11 65.98% | 9.34 282.61% | 5.22 44.13% | 10.16 94.77% | 15.99 57.34% | 22.03K 137,654.31% | |
ev to operating cash flow | -8.75 - | -14.02 60.19% | -9.43 32.73% | -4.07 56.83% | -20.23 396.91% | -7.02 65.29% | 8.59 222.27% | 4.79 44.27% | 8.82 84.27% | 14.03 59.13% | 13.32K 94,797.46% | |
ev to sales | 361.00 - | 2.90 99.20% | 1.81 37.70% | 3.78 108.86% | 7.60 101.11% | 4.80K 63,067.69% | ||||||
free cash flow per share | -0.22 - | -0.20 6.82% | -0.22 10.08% | -0.22 2.32% | -0.16 26.50% | -0.25 56.93% | 0.34 233.69% | 0.43 29.44% | 0.57 31.99% | 1.12 95.49% | 0.00 99.89% | |
free cash flow yield | -0.11 - | -0.07 38.82% | -0.09 33.45% | -0.21 127.92% | -0.04 80.26% | -0.13 219.58% | 0.09 168.45% | 0.13 45.33% | 0.08 34.88% | 0.06 28.85% | 0.00 99.88% | |
graham net net | 0.43 - | 0.48 9.92% | 0.67 39.35% | 0.46 31.04% | 0.93 102.26% | 0.43 53.95% | 0.76 78.86% | 1.20 57.21% | 1.64 36.26% | 2.27 38.54% | 0.00 99.96% | |
graham number | 1.68 - | 1.73 2.74% | 1.97 13.68% | 1.53 22.38% | 2.13 39.92% | 1.92 10.02% | 2.44 26.80% | 5.17 112.20% | 4.15 19.76% | 7.25 74.83% | 0.01 99.90% | |
income quality | 0.81 - | 0.83 2.70% | 0.89 6.70% | 0.99 11.63% | 0.75 24.91% | 0.76 1.28% | 1.09 43.64% | 0.60 44.69% | 1.53 154.60% | 1.40 8.65% | 2.01 43.96% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 Infinity% | 0.41 377.50% | |
interest coverage | -217.45 - | -191.41 11.98% | -203.19 6.16% | -59.95 70.50% | -41.13 31.39% | -27.33 33.56% | -24.72 - | |||||
interest debt per share | 0.00 - | 0.00 13.92% | 0.00 4.46% | 0.00 212.57% | 0.01 36.40% | 0.01 137.76% | 0.01 26.82% | 0.00 96.98% | 0.04 14,523.35% | -0.00 105.38% | 0.00 101.28% | |
inventory turnover | 7.54 - | 3.66 51.42% | 2.78 24.11% | 5.05 81.76% | 3.32 34.27% | |||||||
invested capital | 0.01 - | 0.00 98.43% | 0.02 11,875.40% | 0.01 36.20% | 0.01 36.59% | |||||||
market cap | 88.63M - | 190.50M 114.94% | 198.10M 3.99% | 87.02M 56.07% | 335.49M 285.53% | 197.06M 41.26% | 386.04M 95.90% | 345.73M 10.44% | 699.88M 102.43% | 1.92B 174.73% | 1.91T 99,349.90% | |
net current asset value | 21.34M - | 35.16M 64.76% | 55.28M 57.20% | 39.06M 29.34% | 80.76M 106.79% | 45.52M 43.64% | 86.62M 90.28% | 136.49M 57.58% | 179.15M 31.26% | 245.59M 37.09% | 137.10M 44.18% | |
net debt to ebitda | 0.26 - | 0.67 154.06% | 1.38 105.84% | 0.69 50.07% | 3.11 351.31% | 0.47 84.91% | -2.79 695.19% | -3.15 12.92% | -3.20 1.44% | -2.89 9.59% | -1.55 46.45% | |
net income per share | -0.27 - | -0.24 9.58% | -0.25 3.49% | -0.22 12.85% | -0.21 1.59% | -0.33 54.39% | 0.31 193.46% | 0.72 133.95% | 0.38 47.28% | 0.80 110.43% | 0.00 99.92% | |
operating cash flow per share | -0.22 - | -0.20 7.14% | -0.22 10.42% | -0.22 2.71% | -0.16 26.11% | -0.25 56.37% | 0.34 234.25% | 0.44 29.40% | 0.58 34.23% | 1.12 92.23% | 0.00 99.89% | |
payables turnover | 3.58 - | 4.00 11.69% | 7.91 97.48% | 8.65 9.44% | 3.51 59.40% | |||||||
receivables turnover | 9.71 - | 19.89 104.83% | 21.28 6.99% | 20.52 3.56% | 7.44 63.74% | |||||||
research and ddevelopement to revenue | 39.84 - | 0.18 99.54% | 0.14 24.78% | 0.12 13.20% | 0.09 23.18% | 0.23 153.21% | ||||||
return on tangible assets | -0.48 - | -0.35 26.28% | -0.34 4.69% | -0.43 28.72% | -0.22 50.24% | -0.56 160.86% | 0.28 150.43% | 0.39 37.43% | 0.17 57.41% | 0.24 45.81% | 0.26 6.84% | |
revenue per share | 0.00 - | 0.99 20,299.57% | 1.15 15.75% | 1.36 18.43% | 2.07 52.10% | 0.00 99.83% | ||||||
roe | -0.57 - | -0.44 22.55% | -0.36 17.12% | -0.46 26.06% | -0.23 50.54% | -0.67 194.43% | 0.36 154.33% | 0.44 21.55% | 0.19 56.82% | 0.28 44.87% | 0.18 33.43% | |
roic | -0.56 - | -0.44 20.64% | -0.37 16.95% | -0.47 27.16% | -0.23 50.03% | -0.75 221.66% | 0.34 145.50% | 0.44 28.08% | 0.18 58.08% | 0.26 43.62% | 0.17 36.60% | |
sales general and administrative to revenue | 31.75 - | 0.17 - | 0.17 3.95% | 0.13 19.59% | ||||||||
shareholders equity per share | 0.47 - | 0.55 16.75% | 0.69 24.87% | 0.47 30.87% | 0.94 98.94% | 0.49 47.56% | 0.85 72.03% | 1.64 92.48% | 2.00 22.11% | 2.91 45.26% | 0.00 99.88% | |
stock based compensation to revenue | 7.10 - | 0.04 99.47% | 0.05 40.64% | 0.04 17.99% | 0.04 14.40% | 0.04 3.06% | ||||||
tangible asset value | 21.39M - | 35.24M 64.75% | 55.48M 57.41% | 39.31M 29.14% | 80.96M 105.97% | 50.78M 37.28% | 87.63M 72.55% | 169.60M 93.54% | 206.83M 21.95% | 267.95M 29.55% | 193.83M 27.66% | |
tangible book value per share | 0.47 - | 0.55 16.75% | 0.69 24.87% | 0.47 30.87% | 0.94 98.94% | 0.49 47.56% | 0.85 72.03% | 1.64 92.48% | 2.00 22.11% | 2.59 29.56% | 0.00 99.93% | |
working capital | 23.18M - | 37.97M 63.81% | 56.46M 48.69% | 39.36M 30.29% | 80.92M 105.60% | 45.68M 43.55% | 87.26M 91.05% | 136.49M 56.41% | 183.04M 34.11% | 263.21M 43.80% | 143.27M 45.57% |
All numbers in (except ratios and percentages)